Skip to main content
. 2016 Oct 31;16(11):e40737. doi: 10.5812/hepatmon.40737

Table 2. Diagnostic Performance of LS, APRI, FIB-4, AST/ALT, FibroQ, NAFLD Fiibrosis Score, and Fiibrosis Score by Gutkowski for Determination of Fiibrosis Stage.

Variable AUC ± SE Optimal Cut-Off Sensitivity (%) Specificity (%) Positive Predictive Value (%) Negative Predictive Value (%) P
F1 versus F2 - 4
LS, kPa 0.779 ± 0.08 10.05 61.4 88.9 96.4 31.8 0.009
APRI 0.601 ± 0.09 1.45 59.1 67 89.7 25.1 0.343
FIB-4 0.659 ± 0.08 3.2 47.7 88.9 95.5 26 0.136
AST/ALT 0.601 ± 0.09 0.718 52.3 77.8 92 25 0.343
FibroQ 0.684 ± 0.09 1.34 72.7 66.7 91.5 33.7 0.084
NAFLD fiibrosis score 0.752 ± 0.1 -2.6 71.4 66.7 91.3 32.1 0.051
Fiibrosis score Gutkowski 0.433 ± 0.12 2.96 45.7 66.7 87.2 20.3 0.606
F1-2 versus F3 - 4
LS, kPa 0.739 ± 0.07 12.1 58.6 83.3 80.9 62.4 0.003
APRI 0.527 ± 0.08 1.24 69 50 62.8 59.9 0.734
FIB-4 0.614 ± 0.08 1.93 75.9 50 65 35 0.158
AST/ALT 0.655 ± 0.08 0.795 48.3 75 70.1 54.1 0.054
FibroQ 0.773 ± 0.06 2.695 58.6 91.7 90 64.7 0.001
NAFLD fiibrosis score 0.895 ± 0.05 -3.23 92.3 66.7 77.3 87.3 < 0.0001
Fiibrosis score Gutkowski 0.605 ± 0.1 2.599 80.8 53.3 68.1 70.7 0.267
F1-3 versus F4
LS, kPa 0.842 ± 0.09 19 81.8 92.9 75.7 95.1 0.001
APRI 0.665 ± 0.08 1.848 81.8 57.1 33.6 92.3 0.096
FIB-4 0.766 ± 0.08 2.61 90.9 59.5 37.7 96 0.007
AST/ALT 0.799 ± 0.08 0.939 63.6 88.1 58.6 90.2 0.002
FibroQ 0.916 ± 0.06 3.999 81.8 92.9 75.7 95.1 < 0.0001
NAFLD fiibrosis score 0.910 ± 0.05 -1.095 90 87.1 64.8 97 < 0.0001
Fiibrosis score Gutkowski 0.619 ± 0.09 2.66 90 45.2 30.3 94.4 0.261

Abbreviations: AUC, area under the curve, SE, standard error.